Sign in

NCT07639164Not yet recruiting

Stronger Together: Antenatal Depressive Symptoms - Prevalence and Digital Treatment

Source: ClinicalTrials.gov · Last updated 10 Jun 2026

Brief summary (registry, in English)

The main objective of the current research project is to evaluate the usability, satisfaction of the antenatal iCBT program including telephone coaching for antenatal and postnatal depressive symptoms and collect nationally representative data on population-based screening of antenatal depressive and anxiety symptoms. The overarching hypothesis is that iCBT, with easy access and affordability, is user friendly and well accepted. In addition to examining the treatment response by questionnaires, we will study the infant development comprehensively as well as potential physiological changes associated with antenatal depression or its treatment.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
1000 (estimated)
First submitted
5 Jun 2026
Start date
1 Aug 2026
Primary completion date
30 Dec 2030
Lead sponsor
University of Turku
Diseases
Depression
NCT number
NCT07639164

What you commit to

  • Study type: Interventional
  • Planned participants: 1000
  • From 1 Aug 2026 to the primary completion date, 30 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • lifetime history of psychotic disorder (e.g. schizophrenia, schizoaffective disorder, bipolar disorder, psychotic depression)

Other

  • active suicidal ideation
  • severe substance abuse or dependence
  • participates in another intervention study aiming at treating the symptoms of antenatal depression

Who the study is looking for

  • fluent in written and spoken Finnish or Swedish
  • access to computer or mobile phone with internet
  • between 12 and 22 weeks pregnant
  • screening and baseline score on the EPDS ≥10 points

Age in the registry: 18 years to 55 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University Of Turku
Coordinator of this site? Confirm its status
TurkuFinlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.